Funding for this research was provided by:
Ontario Drug Policy Research Network
Ontario Ministry of Research, Innovation, and Science Early Researcher Award
Received: 14 December 2018
Accepted: 4 August 2019
First Online: 19 August 2019
: William Wong and Murray Krahn have received research support from the Canadian Liver Foundation. Harry L. A. Janssen received grants from AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Janssen, Medimmune, Medtronic, Merck, and Roche and is consultant for AbbVie, Benitec, Bristol Myers Squibb, Gilead Sciences, Janssen, Medimmune, Merck, Roche and Arbutus. None of the other co-authors has any conflict of interest to declare.